AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/220
AHERN,PATRICK,(PADDY),FRANCIS - OBITUARY
Authors: TRELEAVEN J
Citation: J. Treleaven, AHERN,PATRICK,(PADDY),FRANCIS - OBITUARY, BMJ. British medical journal, 316(7143), 1998, pp. 1537-1537
RED-CELL FRAGMENTATION (SCHISTOCYTOSIS) AFTER BONE-MARROW TRANSPLANTATION
Authors: ZOMAS A SASO R POWLES R MACKAY H SINGHAL S TRELEAVEN J MEHTA J
Citation: A. Zomas et al., RED-CELL FRAGMENTATION (SCHISTOCYTOSIS) AFTER BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 22(8), 1998, pp. 777-780
THE IMPORTANCE OF CD34(+) CD33(-) CELLS IN PLATELET ENGRAFTMENT AFTERINTENSIVE THERAPY FOR CANCER-PATIENTS GIVEN PERIPHERAL-BLOOD STEM-CELL RESCUE/
Authors: MILLAR BC MILLAR JL SHEPHERD V BLACKWELL P PORTER H CUNNINGHAM D JUDSON I TRELEAVEN J POWLES RL CATOVSKY D
Citation: Bc. Millar et al., THE IMPORTANCE OF CD34(+) CD33(-) CELLS IN PLATELET ENGRAFTMENT AFTERINTENSIVE THERAPY FOR CANCER-PATIENTS GIVEN PERIPHERAL-BLOOD STEM-CELL RESCUE/, Bone marrow transplantation, 22(5), 1998, pp. 469-475
IMMUNOPHENOTYPIC AND CYTOGENETIC FEATURES IN PATIENTS WITH MINIMALLY DIFFERENTIATED ACUTE MYELOID-LEUKEMIA (AML-M0)
Authors: SASO R KULKARNI S KILLICK S REGE K MEHTA J SWANSBURY J MATUTES E ATRA A MORILLA R POWLES R TRELEAVEN J CATOVSKY D
Citation: R. Saso et al., IMMUNOPHENOTYPIC AND CYTOGENETIC FEATURES IN PATIENTS WITH MINIMALLY DIFFERENTIATED ACUTE MYELOID-LEUKEMIA (AML-M0), Bone marrow transplantation, 21, 1998, pp. 27-27
THERAPY OF ACUTE MEGAKARYOCYTIC LEUKEMIA (AML-M7)
Authors: SASO R KULKARNI S KILLICK S REGE K MEHTA J SWANSBURY J MATUTES E ATRA A MORILLA R POWLES R TRELEAVEN J CATOVSKY D
Citation: R. Saso et al., THERAPY OF ACUTE MEGAKARYOCYTIC LEUKEMIA (AML-M7), Bone marrow transplantation, 21, 1998, pp. 28-28
LONG-TERM OUTCOME OF PATIENTS WHO ARE ALIVE AND WELL 2 YEARS AFTER AUTOGRAFTING FOR ACUTE-LEUKEMIA
Authors: TRELEAVEN J POWLES R SINGHAL S KULKARNI S TAIT D HORTON C MEHTA J
Citation: J. Treleaven et al., LONG-TERM OUTCOME OF PATIENTS WHO ARE ALIVE AND WELL 2 YEARS AFTER AUTOGRAFTING FOR ACUTE-LEUKEMIA, Bone marrow transplantation, 21, 1998, pp. 29-29
PERIPHERAL-BLOOD STEM-CELL AUTOGRAFTS IN ACUTE MYELOID-LEUKEMIA - IS RELAPSE THE ONLY EVENTUAL OUTCOME
Authors: MEHTA J POWLES R TRELEAVEN J KULKARNI S SINGHAL S
Citation: J. Mehta et al., PERIPHERAL-BLOOD STEM-CELL AUTOGRAFTS IN ACUTE MYELOID-LEUKEMIA - IS RELAPSE THE ONLY EVENTUAL OUTCOME, Bone marrow transplantation, 21, 1998, pp. 30-30
FACTORS AFFECTING BLOOD COMPONENT REQUIREMENT AFTER AUTOGRAFT FOR HEMATOLOGICAL MALIGNANCIES
Authors: KULKARNI S POWLES R TRELEAVEN J SINGHAL S MEHTA J SASO R HORTON C
Citation: S. Kulkarni et al., FACTORS AFFECTING BLOOD COMPONENT REQUIREMENT AFTER AUTOGRAFT FOR HEMATOLOGICAL MALIGNANCIES, Bone marrow transplantation, 21, 1998, pp. 34-34
A DOUBLE-BLIND RANDOMIZED STUDY COMPARING THE EFFICACY OF ALLOGENEIC MARROW VERSUS BLOOD STEM-CELL TRANSPLANTATION
Authors: POWLES R KULKARNI S MEHTA J TRELEAVEN J MILLAR B SHEPHERD V TAIT D ANTRUM J NEVILLE F LONG S ROWLAND A SHAW K SINGHAL S
Citation: R. Powles et al., A DOUBLE-BLIND RANDOMIZED STUDY COMPARING THE EFFICACY OF ALLOGENEIC MARROW VERSUS BLOOD STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 125-125
FEASIBILITY OF DONATING BOTH MARROW AND BLOOD-CELLS WITHIN A WEEK IN NORMAL DONORS
Authors: KULKARNI S POWLES R SINGHAL S MEHTA J TRELEAVEN J SHAW K LONG S ROWLAND A
Citation: S. Kulkarni et al., FEASIBILITY OF DONATING BOTH MARROW AND BLOOD-CELLS WITHIN A WEEK IN NORMAL DONORS, Bone marrow transplantation, 21, 1998, pp. 148-148
COMPARISON OF CELL YIELDS IN A SINGLE-CENTER, DOUBLE-BLIND, RANDOMIZED STUDY OF ALLOGENEIC MARROW VS BLOOD STEM-CELL TRANSPLANTATION
Authors: SINGHAL S POWLES R KULKARNI S TRELEAVEN J SASO R LONG S ROWLAND A SHAW K MILLAR B SHEPHERD V CABRAL S MEHTA J
Citation: S. Singhal et al., COMPARISON OF CELL YIELDS IN A SINGLE-CENTER, DOUBLE-BLIND, RANDOMIZED STUDY OF ALLOGENEIC MARROW VS BLOOD STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 149-149
IMMUNOTHERAPY OF ACUTE-LEUKEMIA RELAPSING AFTER ALLOGENEIC TRANSPLANTATION - THE INSEPARABILITY OF GVHD AND GRAFT-VS-LEUKEMIA, AND THE PROBLEM OF EXTRAMEDULLARY RELAPSE
Authors: SINGHAL S POWLES R KULKARNI S TRELEAVEN J MEHTA J
Citation: S. Singhal et al., IMMUNOTHERAPY OF ACUTE-LEUKEMIA RELAPSING AFTER ALLOGENEIC TRANSPLANTATION - THE INSEPARABILITY OF GVHD AND GRAFT-VS-LEUKEMIA, AND THE PROBLEM OF EXTRAMEDULLARY RELAPSE, Bone marrow transplantation, 21, 1998, pp. 245-245
TRANSPLANTS FOR HEMATOLOGICAL MALIGNANCIES IN PATIENTS ABOVE THE AGE OF 50 YEAR
Authors: KULKARNI S POWLES R MEHTA J SINGHAL S HORTON C TRELEAVEN J
Citation: S. Kulkarni et al., TRANSPLANTS FOR HEMATOLOGICAL MALIGNANCIES IN PATIENTS ABOVE THE AGE OF 50 YEAR, Bone marrow transplantation, 21, 1998, pp. 274-274
BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: MEHTA J POWLES R KULKARNI S TRELEAVEN J SINGHAL S CUNNINGHAM D TAIT D CATOVSKY D
Citation: J. Mehta et al., BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA, Bone marrow transplantation, 21, 1998, pp. 275-275
THE IMPLICATIONS OF CAVITY FORMATION ON CHEST-X-RAY IN BONE-MARROW TRANSPLANT PATIENTS
Authors: WILSON PC POWLES R HILL ME HORTON C KULKARNI S TRELEAVEN J
Citation: Pc. Wilson et al., THE IMPLICATIONS OF CAVITY FORMATION ON CHEST-X-RAY IN BONE-MARROW TRANSPLANT PATIENTS, Bone marrow transplantation, 21, 1998, pp. 532-532
OUTCOME OF BONE-MARROW TRANSPLANTATION IN PATIENTS WITH EVIDENCE OF VIRAL-HEPATITIS
Authors: KULKARNI S POWLES R SINGHAL S REILEY U HORTON C TRELEAVEN J
Citation: S. Kulkarni et al., OUTCOME OF BONE-MARROW TRANSPLANTATION IN PATIENTS WITH EVIDENCE OF VIRAL-HEPATITIS, Bone marrow transplantation, 21, 1998, pp. 536-536
2ND CANCERS AND NON-AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES - SINGLE-CENTER EXPERIENCE OF 883 PATIENTS
Authors: KULKARNI S POWLES R SINGHAL S TRELEAVEN J HORTON C MELLER S PINKERTON CR ATRA A TAIT D MEHTA J
Citation: S. Kulkarni et al., 2ND CANCERS AND NON-AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES - SINGLE-CENTER EXPERIENCE OF 883 PATIENTS, Bone marrow transplantation, 21, 1998, pp. 563-563
DETAILED ANALYSIS OF THE CLINICAL STATUS OF LONG-TERM SURVIVORS OF MIS-MATCHED BONE-MARROW TRANSPLANTATION
Authors: MIDDLETON GW KULKARNI S TRELEAVEN J ANTRUM J NEVILLE F SAGE DA KALLON D POWLES RL
Citation: Gw. Middleton et al., DETAILED ANALYSIS OF THE CLINICAL STATUS OF LONG-TERM SURVIVORS OF MIS-MATCHED BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 566-566
COMPARISON OF EQUAL DOSES OF LENOGRASTIM AND FILGRASTIM FOR MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
Authors: KULKARNI S POWLES R TRELEAVEN J SINGHAL S RAJE N RAMIAH V GREGORY K DARK G MILLAR B SHEPHERD V NEVILLE F ANTRUM J HORTON C MILAN S MEHTA J
Citation: S. Kulkarni et al., COMPARISON OF EQUAL DOSES OF LENOGRASTIM AND FILGRASTIM FOR MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES, Bone marrow transplantation, 21, 1998, pp. 680-680
A RANDOMIZED TRIAL OF MAINTENANCE INTERFERON FOLLOWING HIGH-DOSE CHEMOTHERAPY IN MULTIPLE-MYELOMA - RESULTS 51 2 YEARS AFTER THE ACCRUAL OFTHE LAST PATIENT/
Authors: POWLES R CUNNIGHAM D MALPAS J RAJE N MILAN S VINER C MONTES A HICKISH T NICOLSON M JOHNSON P TRELEAVEN J RAYMOND J GORE M
Citation: R. Powles et al., A RANDOMIZED TRIAL OF MAINTENANCE INTERFERON FOLLOWING HIGH-DOSE CHEMOTHERAPY IN MULTIPLE-MYELOMA - RESULTS 51 2 YEARS AFTER THE ACCRUAL OFTHE LAST PATIENT/, Bone marrow transplantation, 21, 1998, pp. 733-733
RATE OF REDUCTION IN SERUM PARAPROTEIN IN PATIENTS WITH IGG MULTIPLE-MYELOMA COMPARING VAMP LIKE CHEMOTHERAPY WITH HIGH-DOSE MELPHALAN (HDM) AS FIRST LINE TREATMENT
Authors: SUMPTER K POWLES R HORTON C MILAN S TRELEAVEN J
Citation: K. Sumpter et al., RATE OF REDUCTION IN SERUM PARAPROTEIN IN PATIENTS WITH IGG MULTIPLE-MYELOMA COMPARING VAMP LIKE CHEMOTHERAPY WITH HIGH-DOSE MELPHALAN (HDM) AS FIRST LINE TREATMENT, Bone marrow transplantation, 21, 1998, pp. 734-734
PLASMA-CELL LEUKEMIA - SINGLE-CENTER STUDY OF 14 PATIENTS
Authors: RAJE N KULKARNI S POWLES R RAMIAH V SASTRY PSRK GREGORY K DARK G TRELEAVEN J
Citation: N. Raje et al., PLASMA-CELL LEUKEMIA - SINGLE-CENTER STUDY OF 14 PATIENTS, Bone marrow transplantation, 21, 1998, pp. 736-736
A SINGLE INSTITUTION REVIEW OF CASES OF AL AMYLOIDOSIS
Authors: SUMPTER K POWLES R RAJE N KULKARNI S RAMIAH V HILL M HORTON C MILAN S MEHTA J SINGHAL S TRELEAVEN J
Citation: K. Sumpter et al., A SINGLE INSTITUTION REVIEW OF CASES OF AL AMYLOIDOSIS, Bone marrow transplantation, 21, 1998, pp. 737-737
RESPONSE OF WALDENSTROMS MACROGLOBULINEMIA (WM) AND IGM MYELOMA (IGM-M) TO INFUSIONAL CHEMOTHERAPY (CVAMP) AND OR AUTOGRAFT/
Authors: KULKARNI S POWLES R TRELEAVEN J RAJE N RAMIAH V GREGORY K DARK G HORTON C MILAN S
Citation: S. Kulkarni et al., RESPONSE OF WALDENSTROMS MACROGLOBULINEMIA (WM) AND IGM MYELOMA (IGM-M) TO INFUSIONAL CHEMOTHERAPY (CVAMP) AND OR AUTOGRAFT/, Bone marrow transplantation, 21, 1998, pp. 742-742
PBSC TRANSPLANTATION IN PATIENTS RECEIVING ABLATIVE DOSES OF RE-186 HEDP FOR SKELETAL SECONDARIES FROM PROSTATE-CANCER
Authors: MCCREADY R TRELEAVEN J ALDEEN A DEARNALEY D POWLES R
Citation: R. Mccready et al., PBSC TRANSPLANTATION IN PATIENTS RECEIVING ABLATIVE DOSES OF RE-186 HEDP FOR SKELETAL SECONDARIES FROM PROSTATE-CANCER, Bone marrow transplantation, 21, 1998, pp. 795-795
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>